Adé, Apolline
Debroucker, Frédérique
Delporte, Laura
De Monclin, Cécile
Fayet, Emmanuel
Legendre, Pierre
Radoszycki, Lise
Chekroun, Michael
Article History
Received: 27 September 2019
Accepted: 27 May 2020
First Online: 5 June 2020
Ethics approval and consent to participate
: As the aim of the study is to determine patients’ satisfaction and priorities, the survey is considered as a patient satisfaction survey (Market Research) and does not correspond to the French legislation of the Loi Jardé (Article L1121–4 amended by Ordinance No. 2016–800 of 16 June 2016 - Art. 1). In this case, submission to an ethical committee is not a requirement and was not done.Patients involved in this study were informed as they registered on the Carenity platform and have consented expressly and specifically to the collection, handling and keeping of their personal and health data. They were also informed of the purposes of the study and gave their explicit consent to the processing of their data before starting the survey by clicking on the “Start the survey” button.
: Not applicable.
: Apolline Adé, Frédérique Debroucker, Laura Delporte, Cécile De Monclin and Emmanuel Fayet are salaried employees of Medtronic France, which funds this study. Pierre Legendre and Lise Radoszycki are salaried employees of Carenity and have no competing interests. Michael CHEKROUN is the founder and CEO of Carenity and has no competing interests.